PCT/1998/22 - World Intellectual Property Organization
PCT/1998/22 - World Intellectual Property Organization
PCT/1998/22 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>22</strong>/<strong>1998</strong><br />
4 Jun/juin <strong>1998</strong> <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 9757<br />
(11) WO 98/23283 (13) A1<br />
(21) <strong>PCT</strong>/US97/21421<br />
(<strong>22</strong>) 25 Nov/nov 1997 (25.11.1997)<br />
(25) en (26) en<br />
(31) 08/755,713 (32) 25 Nov/nov 1996 (33) US<br />
(25.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 38/05, 31/215, C12Q 1/25, 1/68<br />
(54) METHODS OF INHIBITING PROTEIN DEGRA-<br />
DATION TO COMBAT MUSCLE WASTING<br />
PROCEDES PERMETTANT D’INHIBER LA DE-<br />
GRADATION DES PROTEINES POUR COM-<br />
BATTRE LA FONTE MUSCULAIRE<br />
(71) THE PRESIDENT AND FELLOWS OF HAR-<br />
VARD COLLEGE [US/US]; Office of Patents,<br />
Copyrights & Licensing, Harvard University, University<br />
Place, Suite 256, 124 Mt. Auburn Street,<br />
Cambridge, MA 02138 (US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) GOLDBERG, Alfred, L. [US/US]; 171 Crafts<br />
Road, Brookline, MA 02167 (US). BHOITE–<br />
SOLOMON, Vered [IL/US]; 104 Gerry Road,<br />
Chestnut Hill, MA 02167 (US).<br />
(74) IWANICKI, John, P.; Banner & Witcoff, Ltd.,<br />
45th floor, One Financial Center, Boston, MA<br />
02111 (US).<br />
(81) AU CA JP US; EP (AT BE CH DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE).<br />
Published / Publiée : (c)<br />
(11) WO 98/23284 (13) A1<br />
(21) <strong>PCT</strong>/US97/21451<br />
(<strong>22</strong>) 21 Nov/nov 1997 (21.11.1997)<br />
(25) en (26) en<br />
(31) 60/052,525 (32) 27 Nov/nov 1996 (33) US<br />
(27.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 38/19, 38/00<br />
(54) METHOD OF REGULATING NITRIC OXIDE<br />
PRODUCTION<br />
PROCEDE PERMETTANT DE REGULER LA<br />
PRODUCTION DE MONOXYDE D’AZOTE<br />
(71) IMMUNEX CORPORATION [US/US]; 51 University<br />
Street, Seattle, WA 98101 (US).<br />
(72) TROUTT, Anthony, B.; 3412 238th Street, S.W.,<br />
Brier, WA 98036 (US).<br />
(74) PERKINS, Patricia, Anne; Immunex Corporation,<br />
51 University Street, Seattle, WA 98101 (US).<br />
(81) AL AM AU BA BB BG BR CA CN CU CZ EE<br />
GE HU IL IS JP KP KR LC LK LR LT LV MG<br />
MK MN MX NO NZ PL RO SG SI SK SL TR TT<br />
UA UZ VN YU; AP (GH KE LS MW SD SZ UG<br />
ZW); EA (AM AZ BY KG KZ MD RU TJ TM);<br />
EP(ATBECHDEDKESFIFRGBGRIEIT<br />
LU MC NL PT SE); OA (BF BJ CF CG CI CM<br />
GA GN ML MR NE SN TD TG).<br />
(11) WO 98/23285<br />
(21) <strong>PCT</strong>/GB97/03236<br />
(13) A1<br />
(<strong>22</strong>) 26 Nov/nov 1997 (26.11.1997)<br />
(25) en (26) en<br />
(31) 9624801.8 (32) 29 Nov/nov 1996<br />
(29.11.1996)<br />
(31) 9700900.5 (32) 17 Jan/jan 1997<br />
(17.01.1997)<br />
(33) GB<br />
(33) GB<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 38/21 // (A61K 38/21, 31:52)<br />
(54) USE OF A COMBINATION OF PENCICLO-<br />
VIR AND ALPHA–INTERFERON IN THE MA-<br />
NUFACTURE OF A MEDICAMENT FOR THE<br />
TREATMENT OF HEPATITIS B<br />
UTILISATION D’UNE COMBINAISON DE<br />
PENCICLOVIR ET D’ALPHA–INTERFERON<br />
POUR PREPARER UN MEDICAMENT SER-<br />
VANT A TRAITER L’HEPATITE B<br />
(71) SMITHKLINE BEECHAM PLC [GB/GB]; New<br />
Horizons Court, Brentford, Middlesex TW8 9EP<br />
(GB).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) BOON, Ronald, James [GB/GB]; SmithKline<br />
Beecham Pharmaceuticals, New Frontiers<br />
Science Park South, Third Avenue, Harlow, Essex<br />
CM19 5AW (GB). ATKINSON, Gillian, Frances<br />
[GB/GB]; SmithKline Beecham Pharmaceuticals,<br />
New Frontiers Science Park South, Third Avenue,<br />
Harlow, Essex CM19 5AW (GB).<br />
(74) WATERS, David, Martin; SmithKline Beecham,<br />
Corporate <strong>Intellectual</strong> <strong>Property</strong>, Two New Horizons<br />
Court, Brentford, Middlesex TW8 9EP (GB).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />
IL IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MD MG MK MN MW MX NO NZ PL PT<br />
RO RU SD SE SG SI SK SL TJ TM TR TT UA<br />
UG US UZ VN YU ZW; AP (GH KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN ML MR NE SN TD TG).<br />
Published / Publiée : (c)<br />
(11) WO 98/23286 (13) A2<br />
(21) <strong>PCT</strong>/IT97/00296<br />
(<strong>22</strong>) 26 Nov/nov 1997 (26.11.1997)<br />
(25) en (26) en<br />
(31) RM96A000808 (32) 26 Nov/nov 1996 (33) IT<br />
(26.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 39/00, 51/00<br />
(54) IMMUNOCONJUGATES COMPRISING HU-<br />
MAN MONOCLONAL ANTIBODIES OR<br />
FRAGMENTS THEREOF FOR DIAGNOSTIC<br />
AND THERAPY<br />
IMMUNOCONJUGUES COMPRENANT DES<br />
ANTICORPS MONOCLONAUX HUMAINS<br />
OU DES FRAGMENTS DE CES ANTICORPS,<br />
UTILISES A DES FINS DIAGNOSTIQUES ET<br />
THERAPEUTIQUES<br />
(71) ISPROBI S.R.L. [IT/IT]; Viale Liegi, 44, I–00198<br />
Roma (IT).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(71, 72) THALLER, Maria, Cristina [IT/IT]; Via Mario<br />
Romagnoli, 12, I–00136 Roma (IT). BER-<br />
LUTTI, Francesca [IT/IT]; Via Arno, 6, I–00198<br />
Roma (IT). SELAN, Laura [IT/IT]; Via Peccioli,<br />
51, I–00139 Roma (IT). SCHIPPA, Serena<br />
[IT/IT]; Via Campo Catino, 54, I–00135 Roma<br />
(IT). PASSARIELLO, Claudio [IT/IT]; Via Peccioli,<br />
51, I–00139 Roma (IT). CRESTI, Stefania<br />
[IT/IT]; Podere Vernina, 29, F–53020 S. Giovanni<br />
d’Asso (IT). ROSSOLINI, Gian, Maria [IT/IT];<br />
Via del Moro, 8, I–53100 Siena (IT). CATTANI,<br />
Paola [IT/IT]; Via Raffaele Battistini, 21, I–00151<br />
Roma (IT).<br />
(72, 75) CATALANO, Carlo [IT/IT]; Viale Marconi,<br />
903, I–00146 Roma (IT). PASSARIELLO,<br />
Roberto [IT/IT]; Isprobi s.r.l., Viale Liegi, 44,<br />
I–00198 Roma (IT).<br />
(74) BANCHETTI, Marina et al. / etc.; Ing. Barzanò<br />
& Zanardo Roma S.p.A., Via Piemonte, 26,<br />
I–00187 Roma (IT).<br />
(81) AL AM AT AU AZ BA BB BG BR BY CA CH<br />
CN CU CZ DE DK EE ES FI GB GE GH HU ID<br />
IL IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MD MG MK MN MW MX NO NZ PL PT<br />
RO RU SD SE SG SI SK SL TJ TM TR TT UA<br />
UG US UZ VN YU ZW; AP (GH KE LS MW SD<br />
SZ UG ZW); EA (AM AZ BY KG KZ MD RU TJ<br />
TM); EP (AT BE CH DE DK ES FI FR GB GR<br />
IE IT LU MC NL PT SE); OA (BF BJ CF CG CI<br />
CM GA GN ML MR NE SN TD TG).<br />
(11) WO 98/23287 (13) A1<br />
(21) <strong>PCT</strong>/US97/21661<br />
(<strong>22</strong>) 25 Nov/nov 1997 (25.11.1997)<br />
(25) en (26) en<br />
(31) 08/756,014 (32) 25 Nov/nov 1996 (33) US<br />
(25.11.1996)<br />
(31) 60/045,030 (32) 28 Apr/avr 1997 (33) US<br />
(28.04.1997)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 39/00, 38/00, 49/00, 47/36, 47/42, A01N<br />
37/18, C07K 5/00, 14/00<br />
(54) PEPTIDES WHICH MIMIC CANDIDA CARBO-<br />
HYDRATE EPITOPES AND THEIR USE IN A<br />
VACCINE<br />
PEPTIDES IMITANT DES EPITOPES<br />
D’HYDRATES DE CARBONE DE CANDIDA<br />
ET LEUR UTILISATION DANS UN VACCIN<br />
(71) THE RESEARCH AND DEVELOPMENT INS-<br />
TITUTE, INC. [US/US]; Montana State University,<br />
1171 West College, Bozeman, MT 59715<br />
(US).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) CUTLER, Jim, E. [US/US]; Montana<br />
State University, Dept. of Microbiology, Lewis<br />
Hall #109, Bozeman, MT 59717 (US). HAN,<br />
Yongmoon [US/US]; Montana State University,<br />
Dept. of Microbiology, Lewis Hall #109, Bozeman,<br />
MT 59717 (US). GLEE, Pati [US/US];<br />
Montana State University, Dept. of Microbiology,<br />
Lewis Hall #109, Bozeman, MT 59717 (US).<br />
(74) PRICE, Robert, L. et al. / etc.; Lowe Price<br />
LeBlanc & Becker, Suite 300, 99 Canal Center<br />
Plaza, Alexandria, VA <strong>22</strong>314 (US).<br />
(81) AU CA JP US; EP (AT BE CH DE DK ES FI FR<br />
GB GR IE IT LU MC NL PT SE).<br />
(11) WO 98/23288 (13) A1<br />
(21) <strong>PCT</strong>/SE97/01928<br />
(<strong>22</strong>) 18 Nov/nov 1997 (18.11.1997)<br />
(25) en (26) en<br />
(31) 96043<strong>22</strong>–9 (32) 25 Nov/nov 1996 (33) SE<br />
(25.11.1996)<br />
(43) 4 Jun/juin <strong>1998</strong> (04.06.<strong>1998</strong>)<br />
(51) 6 A61K 39/106<br />
(54) A VACCINE COMPOSITION COMPRISING HE-<br />
LICOBACTER PYLORI FLAGELLIN POLYPEP-<br />
TIDE<br />
COMPOSITION DE VACCIN COMPRE-<br />
NANT UN POLYPEPTIDE FLAGELLINE<br />
D’HELICOBACTER PYLORI<br />
(71) ASTRA AKTIEBOLAG [SE/SE]; S–151 85<br />
Södertälje (SE).<br />
(for all designated States except / pour tous les États<br />
désignés sauf US)<br />
(72, 75) BÖLIN, Ingrid [SE/SE]; Oljekvarnsgatan<br />
13 A, S–414 65 Göteborg (SE). BERGLINDH,<br />
Thomas [SE/SE]; Ripvägen 5, S–756 53 Uppsala<br />
(SE). MELLGÅRD, Björn [SE/SE]; Olov<br />
Skötkonungsgatan 7, S–412 66 Göteborg (SE).